Clinical Trials Browser

Withdrawn × Imatinib Mesylate × Other solid neoplasm × Clear all

NCT00159016 2011-04-28

Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study.

Phase 2 Withdrawn

Other solid neoplasm

Metastatic Solid Tumors.